Companies in
Pharmaceutical Industry

BeOne Medicines International GmbH

Pharmaceutical Industry · Basel · Since 2020

BeOne Medicines International GmbH is a biopharmaceutical company that conducts research, development and clinical trials for cancer medicines targeting hematologic malignancies and solid tumors. The company develops an oncology pipeline, runs global clinical studies and collaborates with partners on regulatory approval, manufacturing and distribution of its therapies.

BeOne Medicines I GmbH

Pharmaceutical Industry · Basel · Since 2017

BeOne Medicines I GmbH researches, develops and commercializes oncology medicines and runs global clinical trials across hematologic and solid tumor indications; publicly referenced products include zanubrutinib (BRUKINSA), tislelizumab (TEVIMBRA) and pamiparib.

BeOne Medicines Pharmaceuticals GmbH

Pharmaceutical Industry · Basel · Since 2020

BeOne Medicines Pharmaceuticals GmbH develops and researches medicines for the treatment of cancer and advances them through clinical development. Its pipeline spans clinical and commercial-stage assets across hematologic and solid tumor indications and explores modalities including small molecules, protein degraders (CDACs), monoclonal and bi-/multi‑specific antibodies, antibody‑drug conjugates, cell therapies and cytokine approaches.

Benemedo GmbH

Pharmaceutical Industry · Lachen Sz · Since 2010

Benemedo GmbH is a pharmaceutical and cosmetics company specializing in the development, manufacture and marketing of its own product lines. The company's core activity encompasses the production and distribution of pharmaceuticals and cosmetics, particularly under the brands Vitella, Mediket, Benevet and Benemedio. The company works closely with partners from the pharmaceutical industry and has a strong presence in Europe, North America and Asia.

BEO Therapeutics AG

Pharmaceutical Industry · Zurich · Since 2019

BEO Therapeutics AG develops oral microbiome therapies to counteract diseases caused by metabolic waste products, such as gouty arthritis and (cardio-)metabolic disorders. The company focuses on QPS‑designated bacteria to rebalance the gut microbiome and is evaluating BEO 001 in phase 1/2 clinical trials in patients with hyperuricemia.

BHP Bio Health Pharma AG

Pharmaceutical Industry · Hergiswil Nw · Since 2001

The core activity of BHP Bio Health Pharma AG is investing in the Ukrainian healthcare and hygiene sector, particularly through participations in companies specialized in the production of disinfectants, medical services and hospital management.

Bial SA

Pharmaceutical Industry · Nyon · Since 2018

The core activity of BIAL is the development, manufacture and marketing of medicines and therapeutic solutions in the healthcare sector. The company focuses particularly on research and development of new medicines and therapies to improve the quality of life of people worldwide.

Bioeq AG

Pharmaceutical Industry · Zug · Since 2016

The core activity of Bioeq AG is the development, manufacture and marketing of pharmaceutical products, particularly in the field of medicinal products. The company provides services such as quality control, regulatory affairs, supply chain management and logistics to support the manufacture and distribution of medicinal products.

BiognoSYS AG

Research & Development · Schlieren · Since 2008

The core activity of Biognosys is the development and provision of technologies and services in the field of proteomics, particularly in the areas of large-scale proteomics, biomarker discovery and analysis. The company offers software, kits and contract research services to support customers in life science research and drug development.

BioGntx Global R&D GmbH

Pharmaceutical Industry · Zug · Since 2024

The core activity of BioGntx is the research and development of plant-based substances for medical applications in humans and animals. The company focuses on the research and development of plant-based solutions for unmet medical needs and uses modern, advanced and animal-free research methods.

BIOGRUND International AG

Pharmaceutical Industry · Steinhausen · Since 2024

The company Biogrund develops and produces solutions for the manufacture of solid dosage forms, particularly for the pharmaceutical, nutraceutical and cosmetic industries. The core activities include the development and production of: film coatings, tablet coatings, colorants, sugar coatings, capsule fillings, clean label solutions, excipients, moisture protection solutions, enteric coating solutions, solutions for replacing unwanted additives, capsule coatings, and CBD and hemp products. The company also offers services such as reformulation, customer-specific solutions, technical support and training.

BioInitials AG

Medical Technology Industry · Biel-Benken Bl · Since 2019

BioInitials AG develops non-invasive medical devices and a monitoring platform that analyze saliva biomarkers to assess health status, disease risk factors and disease progression. Biomarker data is combined with other inputs and evaluated using artificial intelligence; project work has included sensor units measuring saliva pH, glucose and impedance.

Biokema S.A.

Pharmaceutical Industry · Bussigny · Since 1959

The core activity of Biokema SA is the development, manufacture and marketing of pharmaceuticals and nutritional supplements for animals, particularly for pets and livestock. The company offers a wide range of products, including anti-parasitic agents, anti-infective agents, immunology products, behavioral medications, gynecology products, anti-inflammatory agents, gastro-enterology products, dermatology products and nutritional supplements. Biokema SA focuses on the health and well-being of animals and works closely with veterinarians and animal owners to offer its products and services.

Bionoltra SA

Research & Development · Petit-Lancy · Since 2008

The core activity of BIONOLTRA SA is the development, manufacture and marketing of medical devices and products for orthopedics and urology, particularly for the treatment of osteoarthritis and other diseases affecting the musculoskeletal system and urology.

BioNTech Switzerland GmbH

Pharmaceutical Industry · Basel · Since 2023

BioSwiss Pharmaceutical SA

Pharmaceutical Industry · Petit-Lancy · Since 2015

BioSwiss Pharmaceutical SA is a pharmaceutical company that manufactures and distributes prescription medicines and medical devices, with a focus on supplying markets that have limited access to treatments. The company commercializes products across multiple therapeutic areas (including anti-infectives, cardiology and oncology) and provides regulatory, supply-chain and licensing services in collaboration with compliant manufacturing partners.

Biotech Concepts GmbH

Research & Development · Zurich · Since 2005

Biotech Concepts GmbH conducts antibiotic research and develops biotechnological production processes. It provides consulting and project management for biotech and pharmaceutical projects, process development (including biocatalysis and fermentation), technology transfer, training and SOP writing, supports API production such as cephalosporins and 7‑ACA, and offers a low‑budget programmable lab/pilot automation system called ARMin.

Biotest (Schweiz) AG

Pharmaceutical Industry · Rupperswil · Since 1989

The core activity of Biotest is the development, production and distribution of biological medicines, particularly in the fields of haematology, clinical immunology and intensive care medicine. The company covers the entire process and value chain, from research and development to the collection of blood plasma in its own collection centres and the production of plasma proteins and quality assurance.

BioVersys AG

Research & Development · Basel · Since 2008

The core activity of Bioversys AG is the development and manufacture of pharmaceuticals, particularly in the field of antibiotic research and the development of therapeutics for various diseases. The company is engaged in the research and development of small molecules, peptides and therapeutic polymers and has experts in the fields of medicinal chemistry, CMC (Chemistry, Manufacturing, Control) and biotechnology on its team.

Bluestone Pharma GmbH

Pharmaceutical Industry · Baar · Since 2013

The core activity of Bluestone Pharma is the development, manufacture and marketing of medical probiotics, in particular oral probiotics, used to treat and prevent various health conditions. The company offers turnkey solutions and private label options to customers and focuses on delivering scientifically proven health benefits through unique probiotic strains in areas with unmet needs.

Blue Wave Therapeutics GmbH

Pharmaceutical Industry · Allschwil · Since 2021

The core activity of Blue Wave Therapeutics GmbH is the development of targeted radionuclide therapies for the treatment of solid tumors.

Boehringer Ingelheim (Schweiz) GmbH

Pharmaceutical Industry · Basel · Since 1957

Botavie SA

Pharmaceutical Industry · Geneva · Since 2000

Botavie SA offers plant-based dietary supplements and health products formulated according to the Unani tradition and markets them online under the BOTAVIE and IRELIA brands.

BridgeBio International GmbH

Pharmaceutical Industry · Zug · Since 2024

BridgeBio International GmbH is a biopharmaceutical company that develops medicines for genetic conditions and manages a pipeline of investigational candidates and approved therapies. The organization uses a hub‑and‑spoke model, partners with academic institutions, and conducts clinical research and trials.

Bristol-Myers Squibb SA

Pharmaceutical Industry · Steinhausen · Since 2002

Bristol-Myers Squibb SA is a global biopharmaceutical company that discovers, develops and delivers medicines for serious diseases. It conducts research and development, runs clinical trials and commercializes treatments in areas such as oncology, HIV and cardiovascular disease.

B SQUARED Sàrl

Pharmaceutical Industry · Neuchâtel · Since 2023

The core activity of B Squared SARL is to provide services to the life sciences industry, particularly in the areas of: bioprocess development and optimization, process modeling and software training, outsourcing and supply chain solutions, and consulting and support for the development and implementation of cell and gene therapies. The company supports customers in the development and implementation of innovative therapies and offers comprehensive services in the areas of research and development, manufacturing, quality assurance and operations.

B'SYS GmbH

Research & Development · Witterswil · Since 2009

The core activity of B'SYS GmbH is to provide services as a Contract Research Organization (CRO) in the field of Ion Channel Discovery for pharmaceutical companies. In particular, the company offers rapid screening services for new substances on ion channel drug targets, including safety services, discovery services, serum shift assays, action potential assays, ion channel trafficking assays, cardiac panel and cardiovascular toxicity tests.

Cabaletta Bio GmbH

Pharmaceutical Industry · Basel · Since 2024

Cabaletta Bio GmbH is a clinical‑stage biotechnology company developing engineered T cell therapies for autoimmune diseases. It applies the Cabaletta Approach to B cell Ablation (CABA®) platform and is advancing rese‑cel, a fully human CD19‑CAR T candidate, in RESET™ Phase 1/2 trials to evaluate transient B‑cell depletion as a means to reset the immune system in conditions such as systemic lupus erythematosus, myositis, systemic sclerosis, generalized myasthenia gravis and pemphigus vulgaris.

Cancer Research and Biotechnology AG

Pharmaceutical Industry · Baar · Since 2017

The core activity of Cancer Research and Biotechnology AG is the development of oncological drugs to combat aggressive types of cancer with high unmet medical needs. The company aims to improve the patient journey through an accelerated clinical regulatory pathway and reduce the burden of conventional treatments.

Canexis Pharma AG

Pharmaceutical Industry · Schlattingen · Since 2020

The core activity of Canexis Pharma AG is the provision of services in the pharmaceutical industry, including the development, manufacture and quality assurance of pharmaceutical products. The company also offers services to non-pharma customers, but the main focus is on the pharmaceutical industry.

GlobeMed Pharma Group AG

Pharmaceutical Industry · Cham · Since 1999

The core activity of Cannapharm AG is the production and distribution of cannabis extracts and other cannabis-based products for medical purposes. The company specializes in the manufacture of high-quality cannabis extracts, which are cultivated and produced in Switzerland, and offers these products to the specialist trade and pharmaceutical industry.

CAPTOR THERAPEUTICS GmbH

Pharmaceutical Industry · Allschwil · Since 2018

The core activity of Captor Therapeutics is the development of medicines, particularly in the early stages of drug development, with a focus on reprogramming proteins to treat previously incurable diseases.

CARBOGEN AMCIS AG

Pharmaceutical Industry · Bubendorf · Since 1982

CARBOGEN AMCIS AG is a CDMO providing development and manufacturing services for drug substance (APIs) and drug product. Services include process development, GMP and non-GMP manufacturing, sterile injectable production, cholesterol and vitamin D specialties, and support functions such as quality management, regulatory affairs and project management.

Cardio-CARE AG

Pharmaceutical Industry · Davos Wolfgang · Since 2019

The core activity of Cardio-CARE AG is the implementation of research projects and services in the field of cardiovascular diseases and personalized medicine. This includes: planning, conducting and analyzing clinical trials on cardiovascular diseases and personalized medicine; supporting the planning, conducting and analyzing of studies on medical devices, such as telemonitoring; biostatistical and bioinformatic consulting; high-throughput genome sequence data analysis; and the application of artificial intelligence and machine learning in data analysis. The company thus offers a combination of research, services and consulting in the field of cardiovascular diseases and personalized medicine.

Catalent Pharma Solutions GmbH

Pharmaceutical Industry · Cham · Since 2000

Catalent Pharma Solutions GmbH is a global contract development and manufacturing organization (CDMO) providing development, manufacturing and supply services to pharmaceutical, biotech and consumer health companies. Services include oral dose and softgel technologies, biologics and specialty manufacturing, clinical supply and formulation and delivery technology support.

CCBD Sàrl

Pharmaceutical Industry · Neuchâtel · Since 2022

CCBD Sàrl is a producer of CBD products, particularly CBD-containing cannabis grown indoors using state-of-the-art technology and in compliance with good manufacturing practices (CGMP). The company's core activity encompasses the cultivation, production, and distribution of CBD products such as flowers, oils, extracts, and other CBD-containing articles.

CDC LAB SA

Pharmaceutical Industry · Plan-Les-Ouates · Since 2021

The core activity of CDC LAB SA is the production and distribution of medical cannabis and related products, in particular dried flowers and pharmaceutical active ingredients, which are manufactured under strict quality controls and GMP guidelines. The company also provides consulting services to healthcare professionals and pharmacies regarding the use and application of medical cannabis.

CDR-Life AG

Research & Development · Horgen · Since 2017

The company develops and commercializes new medicines, particularly T-cell activated cancer medicines, and provides services in the areas of research and development, clinical trials, pharmacology, toxicology and analytics.

Cedem AG

Cosmetics Industry · Zurich · Since 1991

The core activity of CEDEM AG is the development, manufacture and marketing of dietary supplements, vitamins and minerals that meet traditional Swiss quality standards. The company offers a wide range of products tailored to the specific health needs of women, men and children, including products for healthy aging and longevity.

Cederberg GmbH

Pharmaceutical Industry · Binningen · Since 2008

Cederberg GmbH is an international healthcare company focused on developing and commercialising patent-protected medicines and medical devices. Its activities include speciality prescription pharmaceuticals and medical devices for areas such as gastroenterology, gynaecology, urology and endocrinology, and commercial products include Moventig®, Tostran®, Rectogesic® and Gynomunal®.

Celldex Therapeutics Switzerland GmbH

Pharmaceutical Industry · Zug · Since 2018

Celldex Therapeutics Switzerland GmbH is a biopharmaceutical company developing antibody-based immunotherapies. Its pipeline includes barzolvolimab, a humanized monoclonal antibody antagonist of KIT, and CDX-622, a bispecific antibody targeting TSLP and SCF, aimed at treating allergic, inflammatory and autoimmune conditions.

Cellerys AG

Pharmaceutical Industry · Schlieren · Since 2015

The core activity of Cellerys AG is the development of therapies for the treatment of autoimmune diseases, particularly multiple sclerosis, through the application of immunotherapies and cell therapies. The company focuses on the development of EpiTCer-based therapies, which aim to modulate the immune response to autoreactive T-cells. Cellerys conducts clinical trials and collaborates with partners such as Novartis and TETEC to develop and market its therapies.

Cellis AG

Medical Technology Industry · Zug · Since 2024

The core activity of Cellis is the development of cell-based cancer treatments, in particular through the application of a platform technology that enables targeted delivery of active substances directly into cancer cells and modifies the tumor microenvironment to inhibit the growth of cancer cells.

CELLnTEC advanced cell systems AG

Pharmaceutical Industry · Bern · Since 2002

The core activity of CELLnTEC is the development and manufacture of products and technologies for precision cell culture, particularly cell culture media designed for research and clinical applications. The company offers a range of products, including basic and specialized media, primary cells and complementary reagents required for cell culture and the development of cell therapies.

CELL RECEPTOR SA

Research & Development · Geneva · Since 2024

CELL RECEPTOR SA develops a novel cell-biology-based therapy for cancer and autoimmune diseases. It researches an extracellular signalling mechanism and develops compounds that block interactions between tumour cells and platelets to reduce tumour growth, metastasis and chemoresistance.

CellShield AG

Pharmaceutical Industry · Gersau · Since 2022

CellShield AG is an investment-focused company that manages capital allocation, supports revenue-generating projects and aims to secure returns.

cellvie AG

Research & Development · Zurich · Since 2020

The core activity of cellvie is the development of cell-based medicines, in particular by exploiting the therapeutic potential of mitochondria. The company focuses on the development of Therapeutic Mitochondrial Transplantation (TMT), a novel treatment approach aimed at improving cellular energy production and thereby treating various diseases and conditions such as ischemia-reperfusion injury, aging and others.